IP Library › Granted Patent US 6,998,233
Granted Patent B2
US 6,998,233 · App. 10/121,216 · Granted Feb 14, 2006

Methods for ligand discovery

Assignee: Sunesis Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,998,233
App. No.
10/121,216
Granted
Feb 14, 2006
Kind
B2
Abstract

The present invention provides novel methods for ligand discovery. The inventive methods rely on a process termed “tethering” where potential ligands are covalently bonded or “tethered” to a target and subsequently identified.

Claims (24)

1. A method comprising:

a) providing a target having a reactive nucleophile at or near a site of interest;

b) contacting the target with an extender thereby forming a target-extender complex wherein the extender comprises a first functionality that reacts with the nucleophile in the target to form a covalent bond and a second functionality that is capable of forming a disulfide bond, wherein the extender is of the formula:

where R is unsubstituted C 1 –C 20 aliphatic, substituted C 1 –C 20 aliphatic, unsubstituted aryl, and substituted aryl; R′ is H, —SR 1 wherein R 1 is unsubstituted C 1 –C 10 aliphatic, substituted C 1 –C 10 aliphatic, unsubstituted aryl, and substituted aryl; X is a leaving group, and the boxes in each formula represent a binding determinant;

c) contacting the target-extender complex with a candidate ligand that is capable of forming a disulfide bond with said target-extender complex;

d) forming a disulfide bond between the target-extender complex and the candidate ligand thereby forming a target-extender-ligand conjugate; and,

e) identifying the candidate ligand present in the target-extender-ligand conjugate.

2. The method of claim 1 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified by mass spectrometry.

3. The method of claim 1 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using a labeled probe.

4. The method of claim 1 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using a functional assay.

5. The method of claim 1 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using chromatography.

6. The method of claim 1 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using surface plasmon resonance.

7. A method comprising:

a) providing a target having a reactive nucleophile at or near a site of interest;

b) contacting the target with an extender thereby forming a target-extender complex wherein the extender comprises a first functionality that reacts with the nucleophile in the target to form a covalent bond and a second functionality that is capable of forming a disulfide bond, wherein the extender is of the formula:

where R is unsubstituted C 1 –C 20 aliphatic, substituted C 1 –C 20 aliphatic, unsubstituted aryl, and substituted aryl; R′ is H, —SR 1 wherein R 1 is unsubstituted C 1 –C 10 aliphatic, substituted C 1 –C 10 aliphatic, unsubstituted aryl, and substituted aryl; X is a leaving group, and the box in the formula represents a binding determinant;

c) contacting the target-extender complex with a candidate ligand that is capable of forming a disulfide bond with said target-extender complex;

d) forming a disulfide bond between the target-extender complex and the candidate ligand thereby forming a target-extender-ligand conjugate; and

e) identifying the candidate ligand present in the target-extender-ligand conjugate.

8. The method of claim 7 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified by mass spectrometry.

9. The method of claim 7 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using a labeled probe.

10. The method of claim 7 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using a functional assay.

11. The method of claim 7 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using chromatography.

12. The method of claim 7 , wherein the candidate ligand present in the target-extender-ligand conjugate is identified using surface plasmon resonance.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2003
From: WELLS, JIM; ERLANSON, DAN; BRAISTED, ANDREW C.
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 013924/0913 →
Continuity (5)
Continuation In Part 0998154700 · Oct 17, 2001
Division 0910537200 · Jun 26, 1998
Continuation In Part 0999042100 · Nov 21, 2001
Provisional Application 6025229400 · Nov 21, 2000
Related Publication 20020155505A1 · Oct 24, 2002